Gene Query: MRPL50

Dataset Description Geneva Score
Systematic discovery of endogenous human ribonucleoprotein complexes 14.66
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 14.14
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 14.13
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 14.06
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 14.06
DART-seq: an antibody-free method for global m6A detection 13.1
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 12.74
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 12.7
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 12.54
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 12.54
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 12.54
Cleavage Factor Im as a key regulator of 3’ UTR length 12.32
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 12.04
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 11.77
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 11.72
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 11.29
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 10.13
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 10.13
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 9.38
MOF acetyl transferase regulates transcription and respiration in mitochondria 9.36
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 9.34
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 9.3
Comprehensive comparative analysis of 5’ end RNA sequencing methods 9.14
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 9.06
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 8.98
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 8.94
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 8.94
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 8.54
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 8.37
Generating Patterned Kidney Organoids for Studying Development and Diseases 8.28
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 8.19
Global analysis of enhancer targets: Mosaic-seq 8.0
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 7.86
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 7.86
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 7.81
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 7.71
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 7.64
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 7.62
scRNASeq analysis of cycling cardiomyocytes 7.61
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 7.47
RNA-seq in HepG2 and IMR90 cells 7.33
Evolution of a transcriptional regulator from a transmembrane nucleoporin 7.33
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 7.28
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 7.18
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 7.07
Selective expression of long non-coding RNAs in a breast cancer cell progression model 6.88
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 6.79
Effect of PBK knockdown on C4-2 cell transcriptome 6.74
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 6.65
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 6.61
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 6.59
HNF1A deficiency impairs β-cell fate, granule maturation and function 6.53
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 6.52
SLAM-seq for K562 endogenous mRNA decay 6.51
Targeting MTHFD2 in Acute Myeloid Leukemia 6.47
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 6.43
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 6.41
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 6.29
Transcriptional profiling of microglia; current state of the art and future perspectives 6.2
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 6.17
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 6.17
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 6.17
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 6.11
The landscape of alternative splicing in aggressive prostate cancers 6.08
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 6.05
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 6.05
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 6.05
CROP-Seq in Primary Human T Cells 6.02
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 6.02
R430: A potent inbibitor of DNA and RNA viruses 6.0
Total RNA-seq in ALL-SIL upon TLX1 knockdown 5.91
LNCaP treated with iBET 5.89
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 5.88
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 5.83
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 5.74
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 5.65
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 5.61
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 5.54
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 5.54
Tracking distinct RNA populations using efficient and reversible covalent chemistry 5.53
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 5.44
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 5.39
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 5.31
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 5.3
Seletive inhibition of CDK9 in DLBCL cell lines 5.28
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 5.28
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 5.24
Developmental stage specific chromosome architecture in human erythroid cells 5.2
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 5.2
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 5.13
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 5.12
IDH3a KO RNA-seq 5.1
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 5.1
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 5.08
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 5.05
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 5.02
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 4.97
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 4.91
Trans-differentiation of human adult peripheral blood T cells into neurons 4.86
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 4.82
Single-nucleotide-resolution mapping of HBV promoters using CAGE 4.81
An integrative analysis of non-coding regulatory DNA variations associated with autism 4.73
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 4.71
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 4.68
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 4.62
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 4.61
Single-cell analysis of human kidney organoids 4.57
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 4.55
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 4.54
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 4.54
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 4.53
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 4.51
LncRNA expression profiling of ischemic stroke patients 4.5
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 4.46
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 4.42
Cajal bodies are linked to genome conformation [RNA-Seq] 4.37
Cajal bodies are linked to genome conformation 4.37
Identification of renal resident macrophages across species 4.36
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 4.35
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 4.31
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 4.28
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 4.28
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 4.27
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 4.27
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 4.26
Polarized B -cell functions 4.23
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 4.23
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 4.21
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 4.21
TCF7L1 knockdown in pancreatic cancer 4.21
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 4.12
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 4.11
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 4.1
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 4.09
Genome-wide discovery of human splicing branchpoints [RNAse] 4.04
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 4.03
DAOY-Notch1/Notch2 knockout: transcriptome comparison 4.01
The comparison of high-throughput single-cell RNA-seq methods 3.98
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 3.97
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 3.97
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 3.92
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 3.92
Paxillin regulates genomic networks in prostate cancer [LNCaP] 3.92
RNA-seq analysis of control and Myc-induced U2OS cells 3.92
Oncogenic MYC induces a dependency on the spliceosome in human cancer 3.92
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 3.9
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 3.89
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 3.89
Landscape and variation of RNA secondary structure across the human transcriptome 3.88
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 3.87
Identification of global XBP1s target gene expression in human prostate cancer cells 3.87
ETV7 and interferon response 3.83
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 3.83
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 3.83
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 3.83
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 3.81
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 3.81
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 3.77
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 3.76
RNA sequencing of human mammary epithelial cells 3.75
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 3.75
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 3.73
Integrin signaling regulates YAP/TAZ to control skin homeostasis 3.72
Genome-wide analysis of the Integrator complex (HTS) 3.71
Genome-wide analysis of the Integrator complex 3.71
Regulation of protein translation during mitosis 3.71
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 3.7
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 3.69
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 3.68
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 3.68
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 3.68
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 3.68
RNA-Seq with and without RNase treatment in PCa cell lines 3.67
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 3.67
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 3.66
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 3.66
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 3.65
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 3.64
Gene expression signatures of innate lymphoid cells from human blood 3.63
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.6
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 3.6
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 3.58
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 3.56
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 3.54
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 3.54
Transcriptional landscape changes during human embryonic stem cell derivation 3.54
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 3.51
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 3.51
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 3.5
Stem and effector CD8 T-cells from human cancers 3.47
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 3.46
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 3.46
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 3.44
SNHG5 siRNA knock down in HCT116 cells 3.44
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 3.42
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 3.42
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 3.42
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 3.39
Hypoxic transcriptome of SQ20B human head and neck cancer cells 3.39
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 3.36
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 3.36
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 3.36
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 3.33
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 3.33
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 3.32
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 3.32
Sensing self and nonself circular RNAs 3.28
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 3.27
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 3.26
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 3.26
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 3.26
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 3.22
Global Mapping of Human RNA-RNA Interactions 3.22
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 3.19
The cohesin complex prevents Myc-induced replication stress 3.19
Hepatitis C virus functionally sequesters miR-122 3.18
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 3.18
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 3.17
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 3.15
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 3.14
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 3.14
Identification of long noncoding RNAs regulated by p53 3.13
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 3.12
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 3.12
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 3.11
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 3.11
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 3.08
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 3.07
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 3.07
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 3.07
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 3.07
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 3.05
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 3.05
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 3.05
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 3.03
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 3.03
Identification of HOXB13 target genes responsive to BET inhibitors 3.02
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 3.02
ARID1A regulates condensin II distribution and chromosomal partition 3.02
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 3.02
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 3.02
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 3.02
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 2.97
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 2.97
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 2.95
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 2.92
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 2.92
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 2.88
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 2.88
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 2.87
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 2.87
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 2.87
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 2.87
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 2.86
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 2.86
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 2.82
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 2.81
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 2.81
RNA-seq of MDA-MB-231 cells with TET1 knockout 2.75
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 2.75
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 2.73
A transcriptome-wide divergence in protein translation scales with LIN28B expression 2.73
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 2.71
Effect of CHKA knockdown on C4-2 cell transcriptome 2.69
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 2.69
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 2.68
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 2.67
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 2.67
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 2.67
Global transcriptome analysis of HAP1 cells 2.66
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 2.65
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 2.61
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 2.56
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 2.56
RNA-Seq of PRMT1 overexpression ECA109 cells 2.54
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 2.45
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 2.44
Transcriptomic analysis of human tonsillar TFH subsets 2.44
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 2.43
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 2.42
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 2.4
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 2.39
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 2.39
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 2.37
O-glcnAc reprograms cellular energetics 2.34
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 2.34
Transcriptome landscape of HeLa response upon triamcinolone acetonide 2.34
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 2.33
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 2.31
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 2.31
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 2.31
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 2.29
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 2.29
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 2.27
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 2.27
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 2.25
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 2.23
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 2.19
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 2.17
Chromatin landscape of human visceral and subcutaneous adipocytes 2.15
Role of FGFR1 in neuronal devlopment 2.1
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 2.03
H1609088 Human RNA-Sequencing 2.03
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 2.02
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 2.02
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 2.01
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 1.95
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 1.93
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 1.93
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 1.93
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 1.92
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 1.91
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 1.9
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 1.89
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 1.88
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 1.87
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 1.87
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 1.87
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 1.87
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 1.86
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 1.86
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.85
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 1.85
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 1.84
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 1.82
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 1.82
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 1.81
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 1.81
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 1.8
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 1.8
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 1.8
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 1.78
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 1.78
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 1.77
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.74
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 1.74
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 1.72
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 1.72
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 1.72
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 1.69
U2AF1 mutations alter splice site recognition in hematological malignancies 1.69
Single-cell analysis of adult human ovary using 10X genomics 1.67
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 1.63
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 1.63
RNA editing in nascent RNA affects pre-mRNA splicing 1.61
Epigenetic reprogramming of melanoma cells by vitamin C treatment 1.6
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 1.59
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 1.58
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 1.54
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 1.54
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 1.5
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 1.49
mRNA recovered upon RNF219 IP. [RNA-IP] 1.49
Transcriptome of activated human and mouse MAIT cells 1.47
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 1.46
RNA-seq of RKO cells with cTAZ KO or putback 1.45
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 1.44
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 1.44
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 1.43
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 1.37
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 1.35
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 1.33
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 1.33
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 1.33
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 1.32
Hepatocyte maturation 1.32
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 1.31
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 1.31
Zone dependent distinctive gene expression profile of the normal human liver tissue 1.28
Human Treg IL-12 stimulation 1.25
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 1.25
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  1.24
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 1.24
The MEF2B Regulatory Network - RNA-seq data 1.23
The MEF2B Regulatory Network 1.23
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 1.2
Gene expression changes due to PARP knockdown in human cells 1.2
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 1.18
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 1.18
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 1.18
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 1.18
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 1.17
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.17
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 1.16
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 1.15
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 1.13
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 1.13
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 1.12
RNA-seq data 1.11
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 1.11
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 1.11
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 1.08
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 1.07
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 1.07
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 1.07
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 1.01
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 1.01
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 1.0
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 0.99
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.97
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 0.96
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 0.89
RNA seq with AML (NB4) cells upon FTO inhibition 0.89
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 0.88
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 0.88
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.86
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.86
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.86
High-resolution comparative analysis of great ape genomes 0.83
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 0.83
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 0.82
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 0.8
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.78
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 0.78
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 0.77
RNA-seq analyisis of PUM2 knockout cells 0.76
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 0.75
TOP2B disturbed the quality of human oocytes with advanced maternal age 0.74
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 0.72
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 0.69
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.67
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 0.67
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 0.66
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.66
Dermal endothelial cells of type 2 diabetic patients 0.66
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.65
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.65
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.65
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.64
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.64
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.63
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.61
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 0.61
Global transcriptome analysis of WT versus HEB-/- hESCs 0.6
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 0.6
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.6
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 0.59
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 0.59
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.57
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.56
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.56
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 0.56
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 0.55
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 0.55
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 0.55
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 0.54
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 0.54
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 0.53
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.5
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 0.5
Identification of a LIF-responsive replication-competent human β cell 0.46
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 0.43
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.42
Discovering human diabetes-risk gene function with genetics and physiological assays 0.41
Gene profiling of human adult and pediatric liver cancer cells 0.41
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 0.4
Mapping interactions for the TNIP2 hub protein 0.38
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 0.35
Androgen Receptor-regulated genes in prostate cancer cells 0.34
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 0.34
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 0.34
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 0.33
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 0.33
Impact on erythroid progenitor type on erythroid differntiation 0.32
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.31
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.31
SF3B1 Degron knockdown RNA-seq 0.3
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.3
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.3
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.3
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.29
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.27
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 0.26
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 0.25
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 0.25
siRNA-mediated knockdown 0.24
Modulation of nonsense-mediated decay by rapamycin 0.24
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.24
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 0.18
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.13
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 0.12
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.1
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.1
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.09
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.09
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.09
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 0.09
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 0.09
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.08
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.07
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 0.06
Loss of CREBBP results in gene expression repression in lymphoma cells 0.04
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 0.04
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.03
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 0.02
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 0.02
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.01
HEK293 TFAM Knockout Expression Study 0.01
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.0
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation